Cervical Cancer

Stanford Comprehensive Cancer Center
Search for other papers by Stanford Comprehensive Cancer Center in
Current site
Google Scholar

An estimated 11,150 new cases of cervical cancer will be diagnosed in the United States in 2007; 3670 deaths are expected from the disease. Although cervical cancer rates are decreasing among women in the United States, it remains a major world health problem. It is the third most common cancer in women worldwide, with 78% of cases occurring in developing countries. Because persistent human papillomavirus (HPV) infection is considered the most important factor contributing to the development of cervical cancer, immunization against HPV is expected to prevent some cancer. The NCCN Clinical Practice Guidelines in Oncology discuss this and other epidemiologic risk factors, as well as treatment options.

For the most recent version of the guidelines, please visit NCCN.org

The Stanford Cancer Center is an international leader in cancer research and patient care. The mission of the Stanford Clinical Cancer Program is to provide comprehensive care through multidisciplinary collaboration and integrated services; advance cancer therapies through clinical research; and train future leaders in the treatment of patients with cancer. The collaborative approach to cancer research and treatment is a hallmark of this program.

One hundred and sixty faculty members participate in cancer care and clinical research with over 250 active clinical trials. Research on the fundamentals of cancer is conducted in the Center for Molecular and Genetic Medicine and the Center for Clinical Sciences Research. Stanford researchers and physicians have led the way in developing many of the current state-of-the-art radiology, antibody, and biologic therapies that are used to treat cancers. The Cancer Center also encompasses basic population-based research into the causes and consequences of cancer and supports 16 interdisciplinary disease-related programs.

Steven A. Leibel, MD, is the Medical Director of the Stanford Cancer Center and a professor of Radiation Oncology. Irv Weissman, MD (not pictured), is the Director, and Beverly Mitchell, MD (not pictured), is the Deputy Director of the Stanford Cancer Center.

  • Collapse
  • Expand
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 570 163 10
PDF Downloads 397 79 4
EPUB Downloads 0 0 0